Search
Menu
Home
HTB
2000
September
September 2000
Contents
Treatment alerts
Abacavir hypersensitivity cases following an interruption of therapy
Antiretrovirals
Videx EC (ddI, didanosine) – food restrictions
Importance of protease inhibitor plasma levels in patients treated with genotypic-guided therapy
Flavopiridol inhibits cellular processes essential to replication of HIV
Abbott expands early-access program for ABT-378/r (Kaletra)
Roche and Trimeris announce intention to manufacture commercial supplies of anti-HIV fusion inhibitor T-20
PRO-542 shows efficacy in trial
Treatment strategies
Structured treatment interruptions and treatment intensification
Treatment access
Loans to buy AIDS drugs are rejected by Africans
Paediatric care
Adverse effects of perinatal zidovudine exposure on HIV-infected infants
Early cognitive and motor developmental delays in HIV-infected infants
Topical cidofovir clears severe molluscum contagiosum in children with AIDS
Side effects
HAART: enough to make your hair curl?
Coinfections and complications
Prevalence of psoriatic arthritis increasing among HIV-positive black Zambians
Basic science and immunology
Duration of incubation affects subsequent rate of HIV disease progression
Population of HIV-targeted CD8 cells fluctuates with viral load during chronic infection
Vaccines and microbicides
Murabutide inhibits HIV replication in macrophages and dendritic cells
Other news
Scrub typhus: infection reduces viral load in some patients
Immunorestitution disease
PDFs
Volume 1 Number 6 September 2000 PDF
HTB RSS
Early access
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Reduced dosing: a possible crisis response to ART stockouts and closed clinics
5 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate